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ABSTRACT 
BACKGROUND:  
Decompensated liver disease caused  by various modifiable and non 
modifiable factors leads to progression of cirrhosis, jaundice, bleeding 
varcies and other complications which leads to high complications and 
mortality.this study was carried out to predict  whether serum ferritin a 
marker of body  iron stores and inflammation is a valid prognostic marker  in 
advanced liver disease. 
MATERIALS AND METHODS :  
It was a prospective and analytical study of 100 patients admitted in 
our hospital  with dcld  and its complications.the study period was from june 
2016 to july 2017.after informed consent patients were evalvated with 
laboratory investigations, clinical examination.  
INCLUSION CRITERIA; 
1) Patients selected with referral to AASLD guidelines  
2) Both male and female with chronic liver disease with 
decompensatation. 
3) Around 35 to 60 yrs age groups were included 
EXCLUSION CRITERIA 
1) Age  less than35 years and  more than  60 years. 
2) Prenatal women with liver disease. 
3) Primary or secondary malignancy of liver 
4) Patients is on  hepatotoxic drugs 
5) PLWHA 
6) Chronic illness like tuberculosis. 
RESULTS:  
It was found that among enrolled 100 patients after getting informed 
consent, majority are male patients. but sex wise both female and male 
patients  who are all showing high sf   landed up with high mortality in the 
form of  haematemesis with hypovolemic shock and hepatic 
encephalopathy.and also found that serum creatinin and hyponaterimia were 
independent important prognostic marker.By using Roche assay SF levels 
were calculated.normal limit for women was <200 ng/mi and for men 
<300ng/ml.most of  the studied population  had more than 400ng/ml. 
CONCLUSION: 
Serum ferritin is one of  the surrogate marker to predict prognosis in 
the patients of dcld. compared  with well estabilished prognostic model like 
MELD score ,to assess the mortality with SF level  IS  Statistically valid one. 
SO IN Future SF levels will be a one of the best screening independentt  
prognostic marker in people with liver disease. 
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